SynCore Biotechnology Company Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 33

Employees

  • Stock Symbol
  • 4192

Stock Symbol

  • Share Price
  • $0.47
  • (As of Friday Closing)

SynCore Biotechnology Company General Information

Description

SynCore Biotechnology Co Ltd is a biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 84 Chung Shan Road
  • Chung Shan Village
  • Yilan City, Tung-Shan 269
  • Taiwan
+886 03
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ROCO
Corporate Office
  • 84 Chung Shan Road
  • Chung Shan Village
  • Yilan City, Tung-Shan 269
  • Taiwan
+886 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynCore Biotechnology Company Stock Performance

As of 13-Nov-2026, SynCore Biotechnology Company’s stock price is $0.47. Its current market cap is $16.6M with 35.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.47 $0.48 $0.46 - $0.84 $16.6M 35.2M 14.2K -$0.04

SynCore Biotechnology Company Financials Summary

As of 30-Sep-2026, SynCore Biotechnology Company has a trailing 12-month revenue of $817K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 16,391 22,446 30,966 39,051
Revenue 817 867 727 648
EBITDA (1,036) (959) (1,187) (645)
Net Income (1,550) (1,467) (1,692) (1,226)
Total Assets 7,078 8,176 9,664 12,313
Total Debt 321 67 243 69
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SynCore Biotechnology Company Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
SynCore Biotechnology Co Ltd is a biotechnology company. The pipeline products of the company include SB01 and 02, SB03,
Biotechnology
Yilan City, Taiwan
33 As of 2023

London, United Kingdom
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SynCore Biotechnology Company Competitors (31)

One of SynCore Biotechnology Company’s 31 competitors is GSK, a Corporation company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GSK Corporation London, United Kingdom
Roche Corporation Basel, Switzerland
Teva Pharmaceutical Industries Corporation Tel Aviv, Israel
China Resources Pharmaceutical Group Corporation Hong Kong, Hong Kong
Shionogi Corporation Osaka, Japan
You’re viewing 5 of 31 competitors. Get the full list »

SynCore Biotechnology Company Patents

SynCore Biotechnology Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026194998-A1 Fish-derived exosomes for topical use in promoting tissue repair and regeneration Pending 20-Mar-2025
WO-2026179930-A1 Herbal supplements for relieving lung inflammation Pending 27-Feb-2025
AU-2018205544-A1 Treatment of pancreatic cancer Active 05-Jan-2017
AU-2018205544-B2 Treatment of pancreatic cancer Active 05-Jan-2017
CA-3049183-A1 Treatment of pancreatic cancer Active 05-Jan-2017 A61K31/337
To view SynCore Biotechnology Company’s complete patent history, request access »

SynCore Biotechnology Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SynCore Biotechnology Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view SynCore Biotechnology Company’s complete esg history, request access »

SynCore Biotechnology Company FAQs

  • When was SynCore Biotechnology Company founded?

    SynCore Biotechnology Company was founded in 2008.

  • Where is SynCore Biotechnology Company headquartered?

    SynCore Biotechnology Company is headquartered in Yilan City, Taiwan.

  • What is the size of SynCore Biotechnology Company?

    SynCore Biotechnology Company has 33 total employees.

  • What industry is SynCore Biotechnology Company in?

    SynCore Biotechnology Company’s primary industry is Biotechnology.

  • Is SynCore Biotechnology Company a private or public company?

    SynCore Biotechnology Company is a Public company.

  • What is SynCore Biotechnology Company’s stock symbol?

    The ticker symbol for SynCore Biotechnology Company is 4192.

  • What is the current stock price of SynCore Biotechnology Company?

    As of 13-Nov-2026 the stock price of SynCore Biotechnology Company is $0.47.

  • What is the current market cap of SynCore Biotechnology Company?

    The current market capitalization of SynCore Biotechnology Company is $16.6M.

  • What is SynCore Biotechnology Company’s current revenue?

    The trailing twelve month revenue for SynCore Biotechnology Company is $817K.

  • Who are SynCore Biotechnology Company’s competitors?

    GSK, Roche, Teva Pharmaceutical Industries, China Resources Pharmaceutical Group, and Shionogi are some of the 31 competitors of SynCore Biotechnology Company.

  • What is SynCore Biotechnology Company’s annual earnings per share (EPS)?

    SynCore Biotechnology Company’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process